Role of topotecan, vinorelbine, thiotepa and gemcitabine chemotherapy in relapsed/refractory adult acute leukemia

Leuk Lymphoma. 2015;56(10):2962-4. doi: 10.3109/10428194.2015.1018250. Epub 2015 Mar 31.

Authors

Samer A Srour^{1

2}, Emily B Borders³, Mohamad A Cherry², Jennifer Holter², Terence Herman⁴, George B Selby²

Affiliations

¹ a Oklahoma City Veterans Affairs Health Care System , Oklahoma City , Ok , USA.
² b Hematology/Oncology Section, Department of Internal Medicine.
³ c Department of Pharmacy.
⁴ d Department of Radiation Oncology , The University of Oklahoma Health Sciences Center , Oklahoma City , OK , USA.

PMID: 25721752
DOI: 10.3109/10428194.2015.1018250

No abstract available

Publication types

Letter

MeSH terms

Adult
Antineoplastic Combined Chemotherapy Protocols / adverse effects
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Combined Modality Therapy
Deoxycytidine / administration & dosage
Deoxycytidine / analogs & derivatives
Drug Resistance, Neoplasm
Gemcitabine
Humans
Leukemia, Myeloid, Acute / drug therapy*
Leukemia, Myeloid, Acute / pathology*
Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
Precursor Cell Lymphoblastic Leukemia-Lymphoma / pathology*
Recurrence
Retreatment
Thiotepa / administration & dosage
Topotecan / administration & dosage
Treatment Outcome
Vinblastine / administration & dosage
Vinblastine / analogs & derivatives
Vinorelbine

Substances

Deoxycytidine
Vinblastine
Topotecan
Thiotepa
Vinorelbine
Gemcitabine